Yohannes Haile, Allen Seylani, Assal Sadighian. "Five-year survival outcomes in NSCLC patients with concurrent GERD on proton pump inhibitors receiving pembrolizumab or nivolumab: A global study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e20611